Table I.
Baseline profile of patients in the EPRP database.
| Mild-to-Moderate LVSD (n=3,693) | Severe LVSD (n=2,906) | P value | |
|---|---|---|---|
| Age | 70.4 ± 10.0 | 68.4 ± 10.6 | <0.001 |
| Male (%) | 95.5 | 97.6 | <0.001 |
| SBP | 127.8 ± 20.8 | 120.4 ± 20.3 | <0.001 |
| BMI | 29.3 ± 6.1 | 27.6 ± 5.5 | <0.001 |
| DM (%) | 42.1 | 37.3 | <0.001 |
| H/O MI (%) | 40 | 41 | 0.42 |
| COPD (%) | 29.3 | 23.2 | <0.001 |
| PAD (%) | 28.1 | 27.5 | 0.58 |
| CVA (%) | 21.1 | 21.5 | 0.74 |
| Past HF hospitalization (%) | 19.5 | 27.2 | <0.001 |
| Dementia (%) | 3.0 | 2.1 | 0.03 |
| Metastatic cancer (%) | 1.4 | 1.6 | 0.68 |
| BUN (mg/dl) | 26.2 ± 14.8 | 26.7 ± 14.4 | 0.19 |
| Beta-blockers (%) | 64.6 | 65.1 | 0.69 |
| Hemoglobin (gm/dl) | 13.3 ± 1.9 | 13.5 ± 1.9 | <0.001 |
| Serum sodium (meq/l) | 139.2 ± 3.3 | 138.8 ± 3.7 | <0.001 |
| ACEI/ARB (%) | 82.6 | 89.3 | <0.001 |
| Statins (%) | 64.6 | 65.1 | 0.68 |
ACEI/ARB: angiotensin converting enzyme inhibitors/angiotensin receptor blockers; BMI: body mass index; BUN: blood urea nitrogen; COPD: chronic obstructive pulmonary disease; CVA: cerebrovascular accident; DM: diabetes mellitus; EPRP: External Peer Review Program; HF: Heart failure; LVSD: left ventricular systolic dysfunction; MI: myocardial infarction; PAD: peripheral arterial disease; SBP: systolic blood pressure. Data are represented as mean±SD for continuous variables and as percentage for categorical variables.